Press

RVX Releases Human Trial Results For Live HSV-2 Vaccine

SPRINGFIELD, Ill., Oct. 17, 2016 /PRNewswire/ — Rational Vaccines, a biotechnology company at the forefront of herpes research, announced today groundbreaking results from a Phase I Clinical Trial of their potentially revolutionary TheravaxHSV-2vaccine. Although still in the early months following the...

Read more...

New Vaccine-Focused Company Aims To End Herpes

SPRINGFIELD, Ill., Sept. 26, 2016 /PRNewswire/ — Rational Vaccines (RVx), a new biotechnology startup, aims to stop the spread of herpes and improve treatment options for millions of people who live with recurrent herpetic disease. Based on 20 years of pre-clinical studies,...

Read more...

© Rational Vaccines, Inc. Privacy Policy | Terms and Conditions